![Hannah Fry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 198 662 $ au 31/05/2026
Hannah Fry currently works at Protara Therapeutics, Inc., as Chief Accounting Officer & Controller from 2023.
Ms. Fry received her undergraduate degree from the University of San Diego.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/01/2026 | 42 723 ( 0,08% ) | 198 662 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 16/07/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
